Compare CLLS & HTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLLS | HTT |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | France | China |
| Employees | N/A | 101 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.4M | 464.3M |
| IPO Year | 2014 | N/A |
| Metric | CLLS | HTT |
|---|---|---|
| Price | $3.16 | $2.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | 28.7K | ★ 393.5K |
| Earning Date | 05-08-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.98 | N/A |
| P/E Ratio | ★ N/A | $4.14 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.62 | $1.88 |
| 52 Week High | $5.48 | $3.91 |
| Indicator | CLLS | HTT |
|---|---|---|
| Relative Strength Index (RSI) | 44.92 | 48.79 |
| Support Level | $2.86 | $2.63 |
| Resistance Level | $3.40 | $2.93 |
| Average True Range (ATR) | 0.16 | 0.12 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 44.93 | 41.67 |
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
High Templar Tech Ltd is an enabler of financial technology. High Templar is focusing on exploring business opportunities globally to satisfy clients' demand by leveraging its technology know-how and financial service capabilities. The company focus empowering financial institutions with its technological capabilities, helping them improve marketing and operational efficiency and efficiently connect their diverse financial products with online traffic.